Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T17:11:57.791Z Has data issue: false hasContentIssue false

Voluntary physical activity in early life attenuates markers of fatty liver disease in adult male rats fed a high-fat diet

Published online by Cambridge University Press:  11 August 2022

Farqad Abdulqader
Affiliation:
Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand Te Ira Kāwai – The Auckland Regional Biobank, University of Auckland, Auckland, New Zealand
Lennex Yu
Affiliation:
Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand
Mark H. Vickers
Affiliation:
The Liggins Institute, University of Auckland, Auckland, New Zealand
Elwyn C. Firth
Affiliation:
The Liggins Institute, University of Auckland, Auckland, New Zealand
Sue R. McGlashan*
Affiliation:
Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand
*
* Corresponding author: Sue R. McGlashan, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Paediatric fatty liver disease (FLD) can develop into steatohepatitis, cirrhosis and hepatocellular carcinoma in adulthood. We assessed if early life physical exercise reduced the effects of high-fat (HF) diet-induced steatosis. Male HF-fed rats with access to a running wheel from weaning until day (D)60 (early exercise) or from D67 to D120 (late exercise) were compared with control HF- or chow-fed groups with no wheel. At D63 and D120, liver histopathology (Kleiner score), type I collagen and plasma enzymes were assessed. At D63, early life activity significantly reduced histopathology scores (total, portal inflammation, steatosis, ballooning, but not lobular inflammation or fibrosis) and the number of rats affected. At D120, HF control scores were higher than in chow-fed controls, but the effect of activity was selective: early exercise reduced portal inflammation, steatosis, ballooning and fibrosis, but late activity affected only portal inflammation and ballooning. The chow-fed portal inflammation score was significantly less than all HF groups, but lobular inflammation was lower in the HF control group only. The fibrosis score in the HF early exercise and control chow group were lower than in the late exercise and sedentary HF groups, indicating that early life exercise was more effective than when activity was introduced later in life. Plasma biomarkers showed minor between-group differences. The retained effect on liver histopathology rat at D120 after only early life exposure activity suggests that timing of introduction of exercise is critical in reducing FLD scores and prevalence in children, young adults and possibly into adulthood.

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Nutrition Society

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children. Also referred to as paediatric fatty liver disease (pFLD)(1), research to date also suggests that the prevalence is increasing(Reference Mann, Valenti and Scorletti2) which is of major concern given the close association with development of both cirrhosis and cardiometabolic syndrome in adulthood. Prevalence is 3–10 % in the general paediatric population, and 60–70 % in those with metabolic diseases (Nobili, 2013(Reference Nobili, Svegliati-Baroni, Alisi, Miele, Valenti and Vajro3); Mencin, 2011(Reference Mencin and Lavine4); Schwimmer, 2006(Reference Schwimmer, Deutsch, Kahen, Lavine, Stanley and Behling5)). NAFLD is characterised by accumulation of fat in the liver, termed hepatosteatosis, and can progress to non-alcoholic steatohepatitis (NASH), characterised by liver inflammation and hepatocyte ballooning, and in some cases to liver fibrosis and cirrhosis(Reference Pardee, Lavine and Schwimmer6). NAFLD represents a significant public health problem as not only is the prevalence of NASH higher in male children in subpopulations with high BMI, Asian or Hispanic ethnicity, diabetes or prediabetes, or panhypopituitarism(Reference Vos, Abrams and Barlow7Reference Anderson, Howe and Jones9), but also because it is the most rapidly increasing liver disease causing hepatocellular carcinoma in patients younger than 40 years old awaiting liver transplantation(Reference Younossi, Anstee and Marietti10).

Children who are overweight or obese have a higher risk of liver cirrhosis as adults, leading to the suggestion that those with obesity tendency, or have any component of the metabolic syndrome, should be screened by ultrasonography and blood biomarker assessment(11). However, neither these nor MRI-based assessments reliably discriminate NASH from FLD(Reference Ajmera and Loomba12), and prediction of progression from stable FLD to fibrosis is difficult(1). Of the 17 % of all children in Western countries who are overweight or obese, 70–80 % have pFLD(Reference Schwimmer, Newton and Awai13,Reference Giorgio, Prono and Graziano14) ; this is most likely because FLD is the hepatic expression of the metabolic syndrome, the prevalence of which also is very high in the young(Reference Wittcopp and Conroy15,Reference Fornari and Maffeis16) . Although alterations in diet and physical activity (PA) can attenuate NAFLD, the success of such lifestyle alterations has been limited(Reference O’Connor, Evans and Burda17).

Despite a lack of consensus whether pFLD represents the early stages of an age-progressive disease(Reference Nobili, Alisi and Newton18), the increasing prevalence of pFLD may drive an increase in the disease burden of end-stage disease in adulthood. Various aspects limit accurate diagnosis of FLD in children, leading to calls for a better understanding of the pathogenesis of pFLD, which is less well defined than FLD in adults(Reference Mann, Valenti and Scorletti2). More explicit knowledge of how metabolic pathways are perturbed may direct interventions in reducing incidence in the young, as well as testing novel ways of attenuating or slowing progression of pFLD(Reference Leoni, Tovoli and Napoli19). In managing the latter, gastroenterologists recommended PA 40 min/d (mean) on 5 d/week, along with reduction in sedentary (screen) time, although few randomised controlled trials have been conducted, and the knowledge gap of insufficient prescription of PA persists, possibly because in randomised controlled trials centred on childhood obesity, most children do not have NAFLD(Reference Shapiro, Yu and Arin20).

One of the PA characteristics that may have an important effect on organ development and metabolic phenotype is the age at which additional activity is introduced. In our previous study, we used an animal model aiming to mimic a high-fat (HF) feeding environment in young children, where Sprague–Dawley male rats were fed a HF diet from weaning until adulthood (120 d old) and allowed exercise in addition to spontaneous cage activity for 37 d from weaning. We showed body composition, bone morphology and bone marrow molecular changes(Reference Sontam, Vickers and Firth21), with persistent gene effects in bone marrow fat at least 60 d after cessation of the wheel exercise.

Using the same experimental approach, we tested the hypothesis that either early or late exercise, in the setting of a HF diet, would lead to differential effects on markers of FLD and collagen type 1 deposition as compared with sedentary animals fed either a control or HF diet.

Materials and methods

Study design

The experimental design has been described previously(Reference Sontam, Vickers and Firth21). Ethical approval was granted by the University of Auckland Animal Ethics Committee (AEC001432). Animals were bred in-house by the University of Auckland Vernon Janson Animal Unit. Briefly, eighty weanling (23 day old) male Sprague–Dawley rats (n 20 per group) were numbered 1–80 and randomised (using an automatic number generator in Excel) and pair-housed in standard cages in a room maintained with 12: 12 h light/dark cycle, 21°C and ambient humidity, and ad libitum access to water. One group of rats were fed a standard chow diet (18 % energy content from fat, Diet 2018, Envigo) while the other three were fed a HF diet (45 % energy content from fat, D12451, Research Diets) from weaning. The composition of each diet is presented in Table 1, and the fatty acid profile of each diet is provided in online Supplementary Tables 1 and 2. Food and water were checked at regular intervals.

Table 1. Diet composition

The chow-fed group (Chow-SED) and one HF group (HF-SED) were limited to spontaneous cage activity. An early life exercise group was provided with an exercise wheel (Model 80859, Lafayette Instrument Company) from D23 to D60 (HF-EEX); a late exercise (HF-LEX) group had wheel access from D67 to 120. Half of each group (5 pairs, n 10) were culled at D63 and half at D120 for sampling. Wheel exercise data were recorded at 15 min intervals using dedicated monitoring software (Model 86065). Preliminary analyses of the exercise data confirmed that the rats in the HF-EEX group used the wheel preferentially during the dark period (18: 00–6: 00 h) with minimal activity during the day. For this reason, only dark period wheel exercise data were analysed. For the HF-EEX group, the wheels were removed from the housing cages after D63. The study design is summarised in Fig. 1. Animals were fasted overnight, anaesthetised using sodium pentobarbitone (60 mg/kg, IP) and culled by decapitation. Five pairs of rats from each group were culled at either D63 or D120. After the positive effect of EEX on liver histopathological scores was found in a preliminary study of D120 rats, the D63 liver samples were processed using identical protocols as detailed below.

Fig. 1. Summary of the study design. Eighty Sprague–Dawley (SD) weanling males were randomised to a chow diet or high-fat (HF) diet from Day 23 (D23) and housed in cages without a running wheel (sedentary – SED; Chow-SED and HF-SED). Two groups of HF-fed rats had access to a running wheel either between D23 and D60 (early exercise – EEX; HF-EEX) or from D67 to D120 (late exercise – LEX; HF-LEX). N 10 animals from each group were culled at D63 and D120.

Plasma biomarkers

Plasma concentrations of insulin and leptin were analysed by commercially available rat-specific ELISA (90 060 and 90 040, respectively, Crystal Chem). The liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase and alkaline phosphatase concentrations were measured as a measure of animal welfare and liver health using a Hitachi 902 autoanalyser (Hitachi High-Technologies Corporation).

Liver histopathology scoring

Part of the right medial lobe of the liver was excised and placed in 4 % paraformaldehyde for 1 h at room temperature. Routine paraffin-embedded liver sections (5 µm) were collected 100 µm apart and stained with haematoxylin and eosin. Sections were blinded and ten fields of view from five non-consecutive sections per liver were assessed on two independent occasions to ensure consistency of scoring using the Kleiner NASH histological scoring system(Reference Kleiner, Brunt and Van Natta22). A grade for each of the five characteristics according to severity or extent of change between minimal/zero and severe changes detected using the following scoring system: steatosis (G0–G3), lobular inflammation (G0–G3), hepatocyte ballooning (G0–G2), portal inflammation (G0–G1) and fibrosis (G0–G4)(Reference Kleiner, Brunt and Van Natta22). The extent of fibrosis was performed based on stage 0, no fibrosis; stage 1, zone 3 fibrosis; stage 2, zone 3 and portal fibrosis; stage 3, zone 3 and portal fibrosis with bridging fibrosis; and stage 4, cirrhosis. The sum of the scores produced a total NAFLD score.

Fibrotic area

In the Masson’s trichrome-stained slides (from the uneven numbered rats of each group, n 5 per group), histological fields per section were captured (Nikon, Eclipse E400). The digital images at 10× magnification were analysed using a colour threshold detection system developed in ImageJ (version 1.52a, NIH), to isolate the green-stained fibrotic tissue and quantify the fibrotic area occupied as a fraction of the total area of the five random fields (identified fibrotic area/total liver area) × 100.

Immunohistochemical staining of collagen type I

Rabbit polyclonal to collagen type I antibody (Rockland 600-401-103) was used to quantitatively determine density of staining of collagen type I. Briefly, 5-µm liver sections were deparaffinised and rehydrated, and heat-induced epitope retrieval was performed in 10 mM sodium citrate buffer (pH6). Immunostaining was performed using the Novolink Polymer Detection System Kit (Novocastra, Leica Biosystems), following the manufacturer’s instructions. Sections were treated with peroxidase block for 5 min, incubated with protein blocking agent for 5 min, washed with Tris-buffered saline (pH 7·5), incubated overnight at 4°C with rabbit anti-collagen type I antibody (1: 500 dilution), washed again with Tris-buffered saline and incubated with anti-rabbit poly-HRP-IgG for 30 min at room temperature. Collagen type I was visualised with DAB chromogen staining. Sections were counter-stained with haematoxylin and examined under an optical microscope (Nikon, Eclipse E400). Ten random fields of view from each section were captured for image analysis from a total of twelve animals (n 3 per experimental group). The optical density of collagen type I quantified using ImageJ.

Statistical analysis

Data are represented as mean values with their standard error of the mean grade for Kleiner characteristics, total NAFLD score, fibrotic area and collagen type I staining. After testing for normality, one-way ANOVA with Holm–Sidak correction was used to determine the significance of between-group differences. Statistical analysis was undertaken using SigmaPlot (Version 14.0; Systat Software). Statistical significance was defined as P < 0·05.

For histopathological analysis, the number of animals with obvious histopathological compromise, that is, equal to or greater than G3, G2, G1 for the first four liver histology scores listed above, and G2 and G3 for fibrosis, was expressed as a proportion of each treatment group and analysed using a generalised linear model for binomial data.

Results

Body composition, plasma biomarkers and physical activity

Fat and lean mass body phenotype data have been previously reported(Reference Sontam, Vickers and Firth21) and are presented in online Supplementary Fig. 1 to support the pathological findings of the current study. Briefly, at D63 the HF-SED group body weight was greater than other groups, due to the higher fat mass and the fat/lean mass ratio; at D120, body weights were similar between HF-SED and HF-EEX groups and significantly higher than the HF-LEX and Chow-SED groups.

Of the liver enzymes, only plasma ALT was significantly different between groups (Fig. 2(a)). At D63, ALT concentrations were significantly lower in the HF-SED group compared with Chow-SED and HF-EEX (P = 0·01 and 0·043, respectively; F value (–df) 39, 39) = 5·97). However, by D120 ALT was significantly greater in the HF-SED group than Chow-SED (P = 0·029; F value (df 37, 37) = 5·138) as shown in Fig. 2(b). There were no differences across groups for plasma aspartate aminotransferase or alkaline phosphatase concentrations (data not shown).

Fig. 2. Plasma concentrations (mean values with their standard error of the mean) at D63 (left) and D120 (right) of (a), (b) alanine aminotransferase (ALT), and (c), (d) insulin and leptin. Significant intergroup differences (P < 0·05) determined by one-way ANOVA with Holm–Sidak correction are indicated by different letters. Data represent ten animals for Chow-SED and HF-EEX and ten animals for HF-SED.

At D63, plasma insulin and leptin concentrations at D63 were significantly higher in HF-SED group as compared with the Chow-SED or HF-EEX group (P = 0·07 and < 0·001, and F value (df 39, 39) = 2·729 and (df 39, 39) = 16·79, respectively) (Fig. 2(c)). At D120, insulin and leptin concentrations were similar in HF-SED and HF-EEX groups and significantly higher compared with both HF-LEX and Chow-SED groups (F value (df 38, 38) = 7·123 and 15·548 for insulin and leptin, respectively) as presented in Fig. 2(d).

The PA has been published elsewhere(Reference Sontam, Vickers and Firth21). Briefly, the HF-EEX group was allowed running wheel activity from D23, and there was an increase in PA from day 23 at 988·59 (sem 347·05) m/cage per night to 9971·97 (sem 1933·34) m/cage per night at D60. Similar to the HF-EEX animals, the HF-LEX animals exhibited a gradual increase in distance covered (from 1377 (sem 254) m/cage per night to an average of 9907 (sem 2550) m/cage per night). Most activity (∼98 %) occurred during the dark phase of the 24 h light/ dark cycle.

Liver histopathology scores

At D63, five characteristic features of NAFLD and the NAFLD total score were significantly higher in the HF-SED group as compared with the Chow-SED group (Fig. 3). The HF-EEX group had a lower score than those of the HF-SED group for all measures except for lobular inflammation and fibrosis.

Fig. 3. Liver histopathology grading for 63-d-old rats. (a) Representative images of liver haematoxylin and eosin-stained sections from rats exposed to high-fat (HF) diet and limited to cage activity only (HF-SED), HF diet with access to early life wheel exercise (HF-EEX) or to chow diet (Chow-SED). Dashed ovals represent lobular inflammation, white arrows represent ballooned hepatocytes, black arrows represent micro- and macrovesicular steatosis. Scale bar represents 100 μm. (b) Mean values with their standard error of the mean total NAFLD score and the five components. Statistical significance was determined using one-way ANOVA with Holm–Sidak correction. Significant intergroup differences (P < 0·05) are indicated by different letters. Data represent ten animals for Chow-SED and HF-EEX and ten animals for HF-SED.

At D63, Chow-SED rats showed no evidence of steatosis, lobular inflammation, ballooning or fibrosis, but several had portal inflammation (Fig. 3). Overall, the dietary effect was significant for all scored components of the Kleiner scoring (ranging between P < 0·001–0·046) except for stage 3 fibrosis as shown in Table 2. The proportion of rats with histological evidence of steatosis and portal inflammation changes was significantly lower in the HF-EEX than in the HF-SED group (P = 0·008 and 0·017, respectively), although the fraction of EEX group with these five indices was approximately 2–3-fold lower than in the HF-SED group (Fig. 3 and Table 2).

Table 2. The proportion (%) of each of the groups (n 10) with obvious-severe scores of steatosis (grade ≥G3), lobular inflammation (G3), ballooning (G2), portal inflammation (G1) and fibrosis (G2, and G3). Subgroup analyses are presented

At D120, the total and contributing scores of the HF-SED group were significantly higher than in the Chow-SED groups as shown in Fig. 4. The Chow-SED group had a lobular inflammation score lower than that of the HF-SED but not HF-EEX or HF-LEX groups. Portal inflammation grade was similar in HF-EEX, HF-LEX and Chow-SED groups, all being significantly less than in HF-SED. The score of fibrosis was significantly lower in Chow-SED and HF-EEX than in HF-SED and HF-LEX groups.

Fig. 4. Liver histopathology grading for 120-d-old rats. (a) Representative images of liver sections from rats exposed to high-fat (HF) diet and limited to cage activity only (HF-SED), HF diet with access to early life wheel exercise (HF-EEX), HF diet with access to later life wheel exercise (HF-LEX) or to chow diet (Chow-SED) under bright field microscopy stained with haematoxylin and eosin. Scale bar represents 100 μm. In HF-SED, the white arrow indicates necro-inflammatory foci, the black arrowhead indicates zone 3 fibrosis with fibrotic septa formation and black arrows indicates micro- and macro-vesicular steatosis. In HF-EEX, black arrowheads indicate mild micro-vesicular steatosis. In HF-LEX, black arrowheads indicates micro- and macro-vesicular steatosis. The yellow arrow indicates lobular inflammation. (b) Histopathology grade for total and five components of fatty liver disease (FLD) in four groups of 120-d-old rats. Data represent the mean values with their standard error of the mean from ten rats per group. Statistical significance was determined using a one-way ANOVA with Holm–Sidak correction. Significant intergroup differences (P < 0·05) are indicated by different letters. Data represent ten animals per experimental group.

At D120, the proportion of animals with histopathological changes was significantly less in the Chow-SED than in any of the three HF groups (P < 0·001–0·037). Several rats in the Chow-SED group had obvious inflammation and one had stage 2 fibrosis. Compared with the HF-SED group, the number of rats was significantly (P = 0·044–0·003) less in the HF-EEX group for all histological characteristics except steatosis and lobular inflammation; in the HF-LEX group, the count was significantly less (P = 0·044) in the case of ballooning only (Table 2).

Fibrotic area and collagen type I

Liver fibrosis of each group assessed by Masson’s trichrome staining and collagen type I immunostaining are shown (Fig. 5(a)), with area positively staining for collagen type I quantified in Fig. 5(b). The HF diet induced significant portal fibrosis, as indicated by the differences between HF-SED sections relative to Chow-SED (P = 0·007). This effect was ameliorated in both HF-EEX and HF-LEX treatment groups, which were not statistically different from Chow-SED.

Fig. 5. Liver fibrosis. (a) Representative images of liver sections from D120 rats from each group stained with either Masson’s trichrome (top row) or immunolabelled for collagen type I (bottom row). (Top row) in the Masson’s trichrome stained sections: HF-SED white arrowheads indicate thick fibrous septa (bridging septa), white arrows indicate pericellular and perisinusoidal fibrosis; HF-EEX black arrowheads indicate zone 3 fibrosis, and in HF-LEX black arrows indicate zone 3 perisinusoidal/portal and periportal fibrosis. (b) Percentage area (%) stained for collagen type I. Statistical significance was determined using a one-way ANOVA with Holm–Sidak correction where **P < 0·01 compared with Chow-SED. Data represent analysis from ten random fields of view from three animals per experimental group.

Discussion

Our main finding is that compared with other groups, the EEX group had a significantly lower FLD histopathology score and lower prevalence of moderate–severe histological FLD changes in adulthood (D120). This was 60 d after the cessation of voluntary wheel exercise in the EEX group, indicating that the induced liver phenotype was retained long after the PA environment, despite the dietary environment remaining unchanged. The protective effects of EEX on liver pathology were not paralleled by changes in other whole body phenotypic features (D120 body composition, leptin and insulin concentrations) as shown above and as reported in earlier studies(Reference Pardee, Lavine and Schwimmer6,Reference Sontam, Vickers and Firth21) . Thus, retention of the EEX effects on liver histopathology, independent of other biomarkers, may be of a similar nature to those on bone marrow gene expression profile(Reference Sontam, Vickers and Firth21) which had significant between-group differences and retained a ‘memory’ of up- or down-regulation of regulator genes affecting some metabolic pathways disturbed by intake of HF diets. This is consistent with alterations in the early life environment resulting in development programing effects on chronic disease risk across the life course. The prenatal and postnatal factors known to influence pFLD have been reviewed(Reference Mann, Valenti and Scorletti2).

We did not confine scrutiny to the combined NAFLD histopathology score in case each of its five components was influenced independently by EEX. We also included prevalence (number of rats affected) with moderate or worse grades of each of the five liver histopathological features, so that data of differences between individuals and groups would inform on obvious FLD without possible confounding through misinterpretation of subtle changes (lower grades) of each component. This was because NASH is progressive, and differences in milder forms of NAFLD and NASH are unclear(Reference Pardee, Lavine and Schwimmer6). Also, moderate to severe changes in phenotype is a good foundation for studying associations with other biomarkers, comparison across experiments and species, and the impact of different environmental factors on assessment of FLD ranging from steatosis through lobular/portal inflammation, and progression to its more severe and prognostically significant forms (NASH). The latter is characterised by progression of ballooning and fibrosis, but the activity score used to separate mild through severe NAFLD(Reference Kleiner, Brunt and Van Natta22) is founded on adult and paediatric human (not rodent) data.

The severity and prevalence of histopathology change at D120 suggested that the chronic insult of the HF diet had resulted in histopathological features typical of NASH, and the stage 2 fibrosis in HF diet rats already present at D63 was confirmed with staining for the presence of type I collagen in serial sections in three animals per treatment group.

The D120 group mean scores and prevalence of histopathological abnormalities demonstrated that EEX was more effective in limiting liver lesions than was LEX, except in the case of hepatocyte ballooning. The LEX group had access to the running wheel for 53 d, compared with 38 d for the EEX group. Over these periods, the EEX and LEX groups gradually increased daily activity (to 9971 and 9907 m/cage per night, respectively). However, distance decreased to 3254 m/cage per night in the latter part of the LEX period(Reference Sontam, Vickers and Firth21), which might have contributed to the histopathology scores being significantly more favourable in the EEX than the LEX group at D120. The LEX group was also exposed to the HF diet for a much longer period, and HF diets are known to have an inhibitory effect on voluntary PA(Reference Vickers, Breier and McCarthy23). Further, the period of PA acclimatisation from weaning to D60 in HF-EEX and HF-SED groups may have accustomed the EEX rats to undertake more spontaneous cage PA (playing, climbing, etc.) after D63, but we cannot not confirm this as were unable to assess spontaneous cage activity.

A notable feature of PA is that it selectively influenced some histological characteristics and not others. For instance, at D63 in the HF-EEX group the PA had a significant effect of suppressing steatosis, ballooning, portal inflammation, but not lobular inflammation. In the HF-LEX group, the PA had a significant effect on only portal inflammation and ballooning.

The NAFLD scoring demonstrated that individual rats in the CHOW-SED were not immune from FLD, or its progression. At D63, the CHOW-SED group prevalence of all FLD features was zero, except for the 30 % prevalence of portal inflammation. By D120, several CHOW-SED rats had histopathological changes (except ballooning and stage 3 fibrosis), with mean scores that were numerically higher than at D63, except for hepatocyte ballooning (zero at both stages). The results might be explained by differing individual propensity for these rats to develop FLD, likely from (combinations of) genetically inherited variation in control mechanisms of energy and fat metabolism (including food intake) and expected variability in PA across a control population of animals.

That almost all FLD features had responded to voluntary PA by D63 was likely due to the anti-inflammatory effect of PA on the HF diet-induced inflammation in rodents, as indicated by others(Reference Passos, Pereira and Gonçalves24,Reference Gehrke, Biedenbach and Huber25) . The HF-EEX group had retained its significant amelioration effect on NAFLD total and component histopathology scores, except lobular inflammation, by D120. Most striking is that the positive effects of lower (although not statistically significant) score and lower prevalence of fibrosis in the EEX group at D63 were preserved at D120, 60 d after early life wheel activity ceased and in the face of continued exposure to the HF diet. This is an important finding, since it portends that early life PA of particular types (e.g. number of cycles, balance of aerobic/anaerobic activity) may have a lasting effect on attenuating severity and prevalence of liver fibrosis. That said, we do not know how long this effect would have lasted into adulthood beyond D120, and further study is required because the degree and rate of change in fibrosis are the single most important histopathological feature determining risk of progression to NAFLD in young people.

Despite the NAFLD histopathological findings, we did not determine the fraction of total liver volume that was normal/abnormal. This could differ between individuals and groups because of variation in birth size, liver weight gain, and inflammatory and regenerative responses to the HF diet, and effects of PA. If such differences did exist between the D63 and D120 whole liver responses, it might account for the anomalous lower mean plasma ALT concentration in the HF-SED group at D63, compared with the expected higher ALT at D120 after longer exposure to both HF diet and lack of PA. The PA undertaken is also highly variable. Rats’ inclination to move is suppressed by HF diet(Reference Vickers, Gluckman and Coveny26) and which was also demonstrated by another study where voluntary wheel (both daily and 4 week cumulative) distances in adult male mice on a control diet exceeded by 2·5-fold those on HF diet(Reference Gehrke, Biedenbach and Huber25). Various rodent studies(Reference Gehrke, Biedenbach and Huber25,Reference Schon and Weiskirchen27Reference Hajighasem, Farzanegi and Mazaheri30) show that exercise generally decreased ALT plasma concentrations, and that lack of PA increased them, similar to that occurring in human adults with NAFLD(Reference Byambasukh, Zelle and Corpeleijn31,Reference Jang, Lee and Lee32) . We can explain the lower ALT concentration in the HF-SED group at D63 only based on possible effect of a higher fraction of metabolically competent liver tissue in HF-SED at D63 than D120, and of higher spontaneous cage PA in the HF-SED group than the HF-EEX group PA from combined cage and wheel PA. During the course of pFLD, ALT shows variability(Reference Molleston, Schwimmer and Yates33) and is a poor marker of disease activity(Reference Mann, Valenti and Scorletti2).

Current research into FLD in young people is by necessity dominated by the search for possible treatments for established disease in young adults. The understanding of the pathogenesis of pFLD is incomplete, and it remains unclear pFLD is indeed the initial form of the NAFLD disease which progresses with age into and through adulthood(Reference Nobili, Alisi and Newton18). The only ‘treatment’ available for NAFLD is weight loss(Reference Younossi, Anstee and Marietti10), but the loss required to alter NAFLD status and outcomes is not agreed upon(Reference Zelber-Sagi, Ratziu and Oren34). In children with NAFLD, even 10 % weight loss after diet modification and medium intensity exercise for 1 year did not lead to a marked reduction in markers of disease(Reference Pardee, Lavine and Schwimmer6) (Reference Nobili, Marcellini, Devito, Ciampalini, Piemonte, Comparcola, Sartorelli and Angulo35). Due to limited randomised controlled trial data from lifestyle interventions in pFLD, prescription of PA by clinicians was discouraged(Reference Gibson, Lang and Dhawan36).

In our study, the EEX from D22 to D60 resulted in body weight difference (of only 4·4 %) from the HF-SED group, but despite reversion to HF-diet phenotype by D120, the effects on bone marrow and liver tissues were retained. We have outlined that persistent transcriptional control of some candidate pathways possibly accounted for the retained effect on bone metabolism(Reference Sontam, Vickers and Firth21) and suggest that a similar ‘memory’ mechanism might account for the retention of the effect of EEX on liver histopathology grades long after the EEX stimulus had been withdrawn. Due to the bleak outlook in most populations for the future health of people afflicted with advanced NAFLD(Reference Younossi, Anstee and Marietti10), we suggest that the strategic application of EEX might contribute to prevention or attenuation of FLD in children, if further work shows that EEX programming-induced metabolic changes and specific histopathological changes are maintained into mid-late adulthood.

We studied only male rats due to constrained resources, and our results cannot be directly extrapolated to females given the potential sex-specific differences that exist in the prevalence, risk factors, fibrosis and clinical outcomes of NAFLD (Lonardo, 2019(Reference Lonardo, Nascimbeni, Ballestri, Fairweather, Win, Than, Abdelmalek and Suzuki37)). The requirement to house male rats in pairs for animal welfare reasons (to avoid stress responses) precluded obtaining individual data that could have allowed study of individual proclivity to liver abnormality. The total PA volume consists of wheel activity and spontaneous cage activity. Because each of these might affect the other, characterisation of total PA ‘volume’ associated with between-group biomarker differences was not quantified. Given the findings, this is an important matter requiring further study in the exercise prescription area, since the PA that produces the desirable effects may be far less than commonly assumed, equivalent more to a low-moderate than a moderate-high intensity. The low compliance with the latter and with endurance training in both older and younger human sub-populations is well documented.

Early life exercise in the setting of NAFLD has been subject to only scant investigation. We conclude from our study of small groups of rats that voluntary wheel PA in early life had a significant capacity to attenuate histopathological and plasma NAFLD biomarkers within weeks of its introduction and to attenuate features of NAFLD in adulthood, long after the additional voluntary PA ceased. Voluntary wheel PA beginning at a later age was less effective than EEX in suppressing NAFLD scores and prevalence.

Acknowledgements

The authors thank Professor Chris Triggs for his assistance with formal analysis and the application of statistical techniques to analyse liver histopathology data and Dr James Hearn for writing - review and editing of the manuscript.

Author Contributions

F. A. and L. Y. H. conducted laboratory work and data analysis. F. A., M. H. V., E. C. F. and S. R. M., conceptualisation. F. A., M. H. V., E. C. F. and S. R. M. figure preparation, data analysis, writing, review and editing.

Funding

We thank the School of Medical Sciences, The Liggins Institute at the University of Auckland for funding Dr Farqad Abdulqadar’s salary to conduct this work. The original study was funded by Arthritis New Zealand.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

For supplementary material accompanying this paper visit https://doi.org/10.1017/S0007114522002562

References

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity 1, et al. (2018) Paediatric fatty liver disease (PeFLD): all is not NAFLD – Pathophysiological insights and approach to management. J Hepatology 68, 12861299.CrossRefGoogle Scholar
Mann, JP, Valenti, L, Scorletti, E, et al. (2018) Nonalcoholic fatty liver disease in children. Semin Liver Dis 38, 001013.CrossRefGoogle ScholarPubMed
Nobili, V, Svegliati-Baroni, G, Alisi, A, Miele, L, Valenti, L, Vajro, P. (2013) A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol 58(6), 12181229.CrossRefGoogle ScholarPubMed
Mencin, AA, Lavine, JE (2011) Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 14(2), 151157.Google ScholarPubMed
Schwimmer, JB, Deutsch, R, Kahen, T, Lavine, JE, Stanley, C, Behling, C. (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118(4), 13881393.CrossRefGoogle ScholarPubMed
Pardee, PE, Lavine, JE & Schwimmer, JB (2009) Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Semin Pediatr Surg 18, 144151.CrossRefGoogle ScholarPubMed
Vos, MB, Abrams, SH, Barlow, SE, et al. (2017) NASPGHAN Clinical Practice Guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64, 319334.CrossRefGoogle Scholar
Chalasani, N, Younossi, Z, Lavine, JE, et al. (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67, 328357.CrossRefGoogle ScholarPubMed
Anderson, EL, Howe, LD, Jones, HE, et al. (2015) The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One 10, e0140908.CrossRefGoogle ScholarPubMed
Younossi, Z, Anstee, QM, Marietti, M, et al. (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15, 1120.CrossRefGoogle ScholarPubMed
EASO (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59, 112140.Google Scholar
Ajmera, V & Loomba, R (2018) Can elastography differentiate isolated fatty liver from nonalcoholic steatohepatitis? Semin Liver Dis 38, 1420.CrossRefGoogle ScholarPubMed
Schwimmer, JB, Newton, KP, Awai, HI, et al. (2013) Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 38, 12671277.CrossRefGoogle ScholarPubMed
Giorgio, V, Prono, F, Graziano, F, et al. (2013) Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr 13, 40.CrossRefGoogle ScholarPubMed
Wittcopp, C & Conroy, R (2016) Metabolic syndrome in children and adolescents. Pediatr Review 37, 193202.CrossRefGoogle ScholarPubMed
Fornari, E & Maffeis, C (2019) Treatment of metabolic syndrome in children. Front Endocrinol 10, 702.CrossRefGoogle ScholarPubMed
O’Connor, EA, Evans, CV, Burda, BU, et al. (2017) Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US preventive services task force. JAMA 317, 24272444.CrossRefGoogle ScholarPubMed
Nobili, V, Alisi, A, Newton, KP, et al. (2016) Comparison of the phenotype and approach to pediatric v. adult patients with nonalcoholic fatty liver disease. Gastroenterology 150, 17981810.CrossRefGoogle Scholar
Leoni, S, Tovoli, F, Napoli, L, et al. (2018) Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol 24, 33613373.CrossRefGoogle ScholarPubMed
Shapiro, WL, Yu, EL, Arin, JC, et al. (2019) Clinical practice approach to nonalcoholic fatty liver disease by pediatric gastroenterologists in the United States. J Pediatr Gastroenterol Nutr 68, 182189.CrossRefGoogle ScholarPubMed
Sontam, DM, Vickers, MH, Firth, EC, et al. (2017) A memory of early life physical activity is retained in bone marrow of male rats fed a high-fat diet. Front Physiol 8, 476.CrossRefGoogle ScholarPubMed
Kleiner, DE, Brunt, EM, Van Natta, M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 13131321.CrossRefGoogle ScholarPubMed
Vickers, MH, Breier, BH, McCarthy, D, et al. (2003) Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am J Physiol Regul Integr Comp Physiol 285, R271R273.CrossRefGoogle ScholarPubMed
Passos, E, Pereira, CD, Gonçalves, IO, et al. (2015) Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sci 123, 5160.CrossRefGoogle Scholar
Gehrke, N, Biedenbach, J, Huber, Y, et al. (2019) Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters – an animal model of life style intervention in NAFLD. Sci Rep 9, 4007.CrossRefGoogle ScholarPubMed
Vickers, MH, Gluckman, PD, Coveny, AH, et al. (2005) Neonatal leptin treatment reverses developmental programming. Endocrinology 146, 42114216.CrossRefGoogle ScholarPubMed
Schon, HT & Weiskirchen, R (2016) Exercise-induced release of pharmacologically active substances and their relevance for therapy of hepatic injury. Front Pharmacol 7, 283.CrossRefGoogle ScholarPubMed
Linden, MA, Fletcher, JA, Morris, EM, et al. (2015) Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. Med Sci Sports Exerc 47, 556567.CrossRefGoogle ScholarPubMed
Huber, Y, Gehrke, N, Biedenbach, J, et al. (2017) Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu. Cell Death Disease 8, e2893.CrossRefGoogle ScholarPubMed
Hajighasem, A, Farzanegi, P, Mazaheri, Z, et al. (2018) Effects of resveratrol, exercises and their combination on Farnesoid X receptor, Liver X receptor and Sirtuin 1 gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver. PeerJ 6, e5522.CrossRefGoogle ScholarPubMed
Byambasukh, O, Zelle, D & Corpeleijn, E (2019) Physical activity, fatty liver, and glucose metabolism over the life course: the lifelines cohort. Am J Gastroenterol 114, 907915.CrossRefGoogle ScholarPubMed
Jang, DK, Lee, JS, Lee, JK, et al. (2019) Independent association of physical activity with nonalcoholic fatty liver disease and alanine aminotransferase levels. J Clin Med 8, 1013.CrossRefGoogle ScholarPubMed
Molleston, JP, Schwimmer, JB, Yates, KP, et al. (2014) Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels. J Pediatr 164, 707713.e3.CrossRefGoogle ScholarPubMed
Zelber-Sagi, S, Ratziu, V & Oren, R (2011) Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17, 33773389.CrossRefGoogle ScholarPubMed
Nobili, V, Marcellini, M, Devito, R, Ciampalini, P, Piemonte, F, Comparcola, D, Sartorelli, MR, Angulo, P (2006) NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 4(2), 458465.CrossRefGoogle Scholar
Gibson, PS, Lang, S, Dhawan, A, et al. (2017) Systematic review: nutrition and physical activity in the management of paediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 65, 141149.CrossRefGoogle ScholarPubMed
Lonardo, A, Nascimbeni, F, Ballestri, S, Fairweather, D, Win, S, Than, TA, Abdelmalek, MF, Suzuki, A (2019) Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 70(4), 14571469.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Diet composition

Figure 1

Fig. 1. Summary of the study design. Eighty Sprague–Dawley (SD) weanling males were randomised to a chow diet or high-fat (HF) diet from Day 23 (D23) and housed in cages without a running wheel (sedentary – SED; Chow-SED and HF-SED). Two groups of HF-fed rats had access to a running wheel either between D23 and D60 (early exercise – EEX; HF-EEX) or from D67 to D120 (late exercise – LEX; HF-LEX). N 10 animals from each group were culled at D63 and D120.

Figure 2

Fig. 2. Plasma concentrations (mean values with their standard error of the mean) at D63 (left) and D120 (right) of (a), (b) alanine aminotransferase (ALT), and (c), (d) insulin and leptin. Significant intergroup differences (P < 0·05) determined by one-way ANOVA with Holm–Sidak correction are indicated by different letters. Data represent ten animals for Chow-SED and HF-EEX and ten animals for HF-SED.

Figure 3

Fig. 3. Liver histopathology grading for 63-d-old rats. (a) Representative images of liver haematoxylin and eosin-stained sections from rats exposed to high-fat (HF) diet and limited to cage activity only (HF-SED), HF diet with access to early life wheel exercise (HF-EEX) or to chow diet (Chow-SED). Dashed ovals represent lobular inflammation, white arrows represent ballooned hepatocytes, black arrows represent micro- and macrovesicular steatosis. Scale bar represents 100 μm. (b) Mean values with their standard error of the mean total NAFLD score and the five components. Statistical significance was determined using one-way ANOVA with Holm–Sidak correction. Significant intergroup differences (P < 0·05) are indicated by different letters. Data represent ten animals for Chow-SED and HF-EEX and ten animals for HF-SED.

Figure 4

Table 2. The proportion (%) of each of the groups (n 10) with obvious-severe scores of steatosis (grade ≥G3), lobular inflammation (G3), ballooning (G2), portal inflammation (G1) and fibrosis (G2, and G3). Subgroup analyses are presented

Figure 5

Fig. 4. Liver histopathology grading for 120-d-old rats. (a) Representative images of liver sections from rats exposed to high-fat (HF) diet and limited to cage activity only (HF-SED), HF diet with access to early life wheel exercise (HF-EEX), HF diet with access to later life wheel exercise (HF-LEX) or to chow diet (Chow-SED) under bright field microscopy stained with haematoxylin and eosin. Scale bar represents 100 μm. In HF-SED, the white arrow indicates necro-inflammatory foci, the black arrowhead indicates zone 3 fibrosis with fibrotic septa formation and black arrows indicates micro- and macro-vesicular steatosis. In HF-EEX, black arrowheads indicate mild micro-vesicular steatosis. In HF-LEX, black arrowheads indicates micro- and macro-vesicular steatosis. The yellow arrow indicates lobular inflammation. (b) Histopathology grade for total and five components of fatty liver disease (FLD) in four groups of 120-d-old rats. Data represent the mean values with their standard error of the mean from ten rats per group. Statistical significance was determined using a one-way ANOVA with Holm–Sidak correction. Significant intergroup differences (P < 0·05) are indicated by different letters. Data represent ten animals per experimental group.

Figure 6

Fig. 5. Liver fibrosis. (a) Representative images of liver sections from D120 rats from each group stained with either Masson’s trichrome (top row) or immunolabelled for collagen type I (bottom row). (Top row) in the Masson’s trichrome stained sections: HF-SED white arrowheads indicate thick fibrous septa (bridging septa), white arrows indicate pericellular and perisinusoidal fibrosis; HF-EEX black arrowheads indicate zone 3 fibrosis, and in HF-LEX black arrows indicate zone 3 perisinusoidal/portal and periportal fibrosis. (b) Percentage area (%) stained for collagen type I. Statistical significance was determined using a one-way ANOVA with Holm–Sidak correction where **P < 0·01 compared with Chow-SED. Data represent analysis from ten random fields of view from three animals per experimental group.

Supplementary material: File

Abdulqader et al. supplementary material

Tables S1-S2

Download Abdulqader et al. supplementary material(File)
File 25.6 KB